학술논문
177P Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience.
Document Type
Article
Author
Source
Subject
*HORMONE receptor positive breast cancer
*METASTATIC breast cancer
*THERAPEUTICS
*
*
Language
ISSN
0923-7534